Anastasia M. Rivkin
Arnold and Marie Schwartz College of Pharmacy
Long Island University
Brooklyn
NY 11201
USA
Name/email consistency: high
- Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug-drug interactions in medical intensive care patients. Rivkin, A., Yin, H. J. Crit. Care (2011)
- Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B. Rivkin, A. Drugs. Today (2007)
- Admissions to a medical intensive care unit related to adverse drug reactions. Rivkin, A. Am. J. Health. Syst. Pharm (2007)
- Thrombotic thrombocytopenic purpura induced by metronidazole vaginal gel. Rivkin, A. Pharmacotherapy (2007)
- Lubiprostone: chloride channel activator for chronic constipation. Rivkin, A., Chagan, L. Clin. Ther (2006)
- Epoetin alfa for the treatment of combination therapy-induced hemolytic anemia in patients infected with hepatitis C virus. Rivkin, A.M., Chawla, S. Pharmacotherapy (2005)
- Hepatocellular enzyme elevations in a patient receiving ceftriaxone. Rivkin, A.M. Am. J. Health. Syst. Pharm (2005)
- A review of entecavir in the treatment of chronic hepatitis B infection. Rivkin, A. Curr. Med. Res. Opin (2005)